Q4 2020 Matinas BioPharma Holdings Inc Earnings Call Transcript
Hello, and welcome to the Matinas BioPharma Fourth Quarter and Full Year 2020 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo, Investor Relations representative for Matinas BioPharma. Peter, you may begin.
Thank you, Kevin. Good morning, everyone, and thank you for joining the Matinas BioPharma Fourth Quarter and Full Year 2020 Results Conference Call. Earlier this morning, we issued a press release with our financial results along with business updates. The release is available on the Matinas BioPharma website under the Investors section.
Speaking on today's call will be Jerry Jabbour, Chief Executive Officer, who will discuss the company's corporate progress and key milestones; Dr. Terry Ferguson, Chief Medical Officer, who will discuss LYPDISO; Dr. Raphael Mannino, Chief Scientific Officer, who will provide an overview of our LNC platform delivery technology; Dr. Terry Matkovits, Chief
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
